S
Neuronetics, Inc.
STIM · NASDAQ · Healthcare · 230M
Closing price
$2.13
-0.47% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
5.4×
Enterprise value / EBITDAEV/EBITDA
-7.3×
Free cash flow yieldFCF yield
-15.1%
Return on equityROE
-174.3%
Operating margin
-21.1%
Net debt / EBITDAbalance-sheet strength
-2.1×
Interest coverage
-3.7×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.